Seres Therapeutics (MCRB) Non-Current Deffered Revenue (2017 - 2024)
Seres Therapeutics' Non-Current Deffered Revenue was $95.36 million in Q2 2024, up 0.5% from $94.93 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Non-Current Deffered Revenue (2017 - 2024) Analysis & Trends
From Q4 2017 onward, Seres Therapeutics has reported Non-Current Deffered Revenue for 26 quarters.
- Non-Current Deffered Revenue has now increased for three consecutive years, though with a five-year compound annual growth rate of -4.0% (FY2018 to FY2023).
- In earlier years, Non-Current Deffered Revenue was $92.43 million in FY2022 (+6.2%), $87 million in FY2021 (+1.7%), $85.57 million in FY2020 (-4.0%) and $89.11 million in FY2019 (-23.7%).
- Compared with a year earlier, Non-Current Deffered Revenue has increased for nine straight quarters, with growth averaging 4.7% over the last eight quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q1 2023 (growth of 15.8%); the worst was Q1 2020 (a decline of 24.4%).
- Per Business Quant data, MCRB's Non-Current Deffered Revenue in the three quarters before Q2 2024 was $95.36 million (Q1 2024), $95.36 million (Q4 2023) and $95.06 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Seres Therapeutics | 20.53 Mn | -118.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 95.36 Mn |
| Mar 31, 2024 | 95.36 Mn |
| Dec 31, 2023 | 95.36 Mn |
| Sep 30, 2023 | 95.06 Mn |
| Jun 30, 2023 | 94.93 Mn |
| Mar 31, 2023 | 94.84 Mn |
| Dec 31, 2022 | 92.43 Mn |
| Sep 30, 2022 | 92.80 Mn |
| Jun 30, 2022 | 90.01 Mn |
| Mar 31, 2022 | 81.88 Mn |
| Dec 31, 2021 | 87.00 Mn |
| Sep 30, 2021 | 89.41 Mn |
| Jun 30, 2021 | 78.43 Mn |
| Mar 31, 2021 | 82.28 Mn |
| Dec 31, 2020 | 85.57 Mn |
| Sep 30, 2020 | 82.83 Mn |
| Jun 30, 2020 | 80.38 Mn |
| Mar 31, 2020 | 84.64 Mn |
| Dec 31, 2019 | 89.11 Mn |
| Sep 30, 2019 | 94.22 Mn |
API Access
Seres Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();